XH

Xiao Hu

LY Lycera: 4 patents #21 of 35Top 60%
Pfizer: 4 patents #1,262 of 5,153Top 25%
Overall (All Time): #632,154 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10532088 Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods Gary D. Glick, Peter L. Toogood, Thomas D. Aicher, Laura L. Celeste, Xikui Liu +2 more 2020-01-14
10208061 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Peter L. Toogood 2019-02-19
9802958 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease Thomas D. Aicher, Peter L. Toogood 2017-10-31
9394315 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Peter L. Toogood 2016-07-19
8445520 Tricyclic compounds, compositions, and methods Hengmiao Cheng, Kevin D. Jerome, Mark Obukowicz, Lisa M. Olson, Paul V. Rucker +1 more 2013-05-21
8158660 Tricyclic compounds, compositions and methods Hengmiao Cheng, Kevin D. Jerome, Mark Obukowicz, Lisa M. Olson, Paul V. Rucker +1 more 2012-04-17
7786097 Tricyclic compounds, compositions and methods Hengmiao Cheng, Rajesh Devraj, Gary A Decresenzo, Kevin D. Jerome, Mark Obukowicz +3 more 2010-08-31
7598231 Tricyclic compound, compositions, and methods Hengmiao Cheng, Rajesh Devraj, Gary A Decresenzo, Kevin D. Jerome, Mark Obukowicz +3 more 2009-10-06